US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Atossa Genetics

4.21

-0.2100-4.75%

Volume:43.95K

Turnover:187.22K

Market Cap:36.25M

PE:-1.20

High:4.48

Open:4.38

Low:4.15

Close:4.42

52wk High:19.35

52wk Low:3.76

Shares:8.61M

Float Shares:8.61M

Volume Ratio:0.37

T/O Rate:0.51%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.5221

EPS(LYR):-3.0396

ROE:-48.89%

ROA:-29.87%

PB:0.73

PE(LYR):-1.39

Loading ...

Overview Company News Filings

Atossa Therapeutics Granted U.S. Patent for Enteric Oral (Z)-Endoxifen Formulations and Treatment Methods

Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen

THOMSON REUTERS

Atossa Therapeutics and Insilico Medicine Identify (Z)-Endoxifen as Potential Glioblastoma Treatment in AI-Driven Study

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Atossa Therapeutics Q3 net loss widens as operating costs rise

Atossa Therapeutics Secures Israeli Patent for (Z)-Endoxifen, Strengthening Global IP Portfolio

Atossa Therapeutics Q3 Pretax Profit USD -8.692 Million

THOMSON REUTERS

Atossa Therapeutics Q3 Operating Expenses USD 9.251 Million

THOMSON REUTERS

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Atossa Therapeutics Inc expected to post a loss of 7 cents a share - Earnings Preview

Atossa Therapeutics Advances RECAST Trial Testing (Z)-Endoxifen for DCIS

Health Rounds: Scientists find way to make breast cancer drug work better for younger women

Atossa Therapeutics appoints Mark Daniel as CFO

Atossa Appoints Mark Daniel, Cpa, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness

THOMSON REUTERS

BRIEF-Atossa Therapeutics - Appoints Mark Daniel As CFO - SEC Filing

Atossa Therapeutics - Heather Rees Steps Down as CFO, Assists Transition Until Nov 15 - SEC Filing

THOMSON REUTERS

Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer to Lead Commercial Readiness

Atossa Therapeutics Granted Israeli Patent for High-Purity Z-Endoxifen Formulations

BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling Activities

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ATOS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ATOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","market":"US","secType":"STK","nameCN":"Atossa Genetics","latestPrice":4.21,"timestamp":1771621200000,"preClose":4.42,"halted":0,"volume":43948,"delay":0,"changeRate":-0.04751131221719456,"floatShares":8606660,"shares":8611428,"eps":-3.522115,"marketStatus":"Pre-Mkt","change":-0.21,"latestTime":"02-23 08:20:52 EST","open":4.38,"high":4.4763,"low":4.15,"amount":187218.8447684,"amplitude":0.073824,"askPrice":4.55,"askSize":100,"bidPrice":4.02,"bidSize":50,"shortable":3,"etf":0,"ttmEps":-3.522115,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1352350800000,"exchange":"NASDAQ","adjPreClose":4.21,"postHourTrading":{"tag":"盘后","latestPrice":4.09,"preClose":4.21,"latestTime":"18:26 EST","volume":1063,"amount":4301.4925,"timestamp":1771629984235,"change":-0.12,"changeRate":-0.028504,"amplitude":0.047245},"volumeRatio":0.3667884060571457,"impliedVol":0.3927,"impliedVolPercentile":0.1124},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATOS\",,,,,undefined,":{"symbol":"ATOS","floatShares":8606660,"roa":"-29.87%","roe":"-48.89%","lyrEps":-3.039585,"volumeRatio":0.3667884060571457,"shares":8611428,"dividePrice":0,"high":4.4763,"amplitude":0.073824,"preClose":4.42,"low":4.15,"week52Low":3.76,"pbRate":"0.73","week52High":19.35,"institutionHeld":0,"latestPrice":4.21,"committee":-0.333333,"eps":-3.522115,"divideRate":0,"volume":43948,"delay":0,"ttmEps":-3.522115,"open":4.38,"prevYearClose":8.85,"prevWeekClose":4.21,"prevMonthClose":8.475,"prevQuarterClose":8.85,"fiveDayClose":3.94,"twentyDayClose":9.819,"sixtyDayClose":11.703},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-02","symbol":"ATOS","defaultRemindTime":1770042600000,"type":"split","dateTimestamp":1770008400000,"forFactor":15,"toFactor":1,"ratio":15},{"market":"US","date":"2025-11-12","symbol":"ATOS","fiscalQuarterEnding":"2025/09","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-08-12","symbol":"ATOS","fiscalQuarterEnding":"2025/06","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-13","symbol":"ATOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.05},{"market":"US","date":"2025-03-25","symbol":"ATOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.06,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"pre","actualEps":-0.05}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1749099600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATOS","date":"2026-02-20","current":-1.195305,"percent":0.995935,"low":-56.54649,"twenty":-7.786223,"median":-4.867891,"eighty":-3.474716,"high":-1.124223,"avg":-7.389212,"sd":7.015859,"marketCap":38062529},"quantilePoints":[{"date":"2021-02-26","current":-15.01868,"twenty":-1.773381,"median":-0.852232,"eighty":-0.481914,"marketCap":194682041},{"date":"2021-03-05","current":-12.313109,"twenty":-1.783844,"median":-0.852043,"eighty":-0.481618,"marketCap":159610644},{"date":"2021-03-12","current":-16.067779,"twenty":-1.817246,"median":-0.852421,"eighty":-0.481618,"marketCap":208281154},{"date":"2021-03-19","current":-15.349974,"twenty":-1.829769,"median":-0.853652,"eighty":-0.481618,"marketCap":198976498},{"date":"2021-03-26","current":-14.819522,"twenty":-1.836981,"median":-0.855734,"eighty":-0.481914,"marketCap":192100420},{"date":"2021-04-01","current":-14.638806,"twenty":-1.850765,"median":-0.855734,"eighty":-0.481914,"marketCap":260980634},{"date":"2021-04-09","current":-13.689995,"twenty":-1.873373,"median":-0.858429,"eighty":-0.481618,"marketCap":244065223},{"date":"2021-04-16","current":-11.046877,"twenty":-1.897673,"median":-0.863848,"eighty":-0.481618,"marketCap":196943719},{"date":"2021-04-23","current":-11.995688,"twenty":-1.909665,"median":-0.867984,"eighty":-0.481618,"marketCap":213859131},{"date":"2021-04-30","current":-15.790934,"twenty":-1.922392,"median":-0.868606,"eighty":-0.481618,"marketCap":281520777},{"date":"2021-05-07","current":-18.569597,"twenty":-1.952976,"median":-0.869364,"eighty":-0.481618,"marketCap":331058768},{"date":"2021-05-14","current":-19.023761,"twenty":-1.97085,"median":-0.879213,"eighty":-0.481618,"marketCap":350390667},{"date":"2021-05-21","current":-21.188534,"twenty":-1.984771,"median":-0.8803,"eighty":-0.481618,"marketCap":390262708},{"date":"2021-05-28","current":-21.122935,"twenty":-2.009032,"median":-0.885764,"eighty":-0.481618,"marketCap":389054464},{"date":"2021-06-04","current":-30.30682,"twenty":-2.028564,"median":-0.885764,"eighty":-0.481618,"marketCap":558208580},{"date":"2021-06-11","current":-28.273245,"twenty":-2.039544,"median":-0.885768,"eighty":-0.481618,"marketCap":520753026},{"date":"2021-06-18","current":-35.095559,"twenty":-2.055075,"median":-0.895581,"eighty":-0.481618,"marketCap":646410368},{"date":"2021-06-25","current":-56.54649,"twenty":-2.067664,"median":-0.905057,"eighty":-0.481618,"marketCap":1041506052},{"date":"2021-07-02","current":-35.226758,"twenty":-2.087317,"median":-0.911656,"eighty":-0.481618,"marketCap":648826856},{"date":"2021-07-09","current":-34.898762,"twenty":-2.107728,"median":-0.917115,"eighty":-0.481618,"marketCap":642785637},{"date":"2021-07-16","current":-29.519629,"twenty":-2.115375,"median":-0.922574,"eighty":-0.481618,"marketCap":543709656},{"date":"2021-07-23","current":-27.420456,"twenty":-2.139537,"median":-0.934503,"eighty":-0.481618,"marketCap":505045858},{"date":"2021-07-30","current":-20.525084,"twenty":-2.160122,"median":-0.943574,"eighty":-0.481618,"marketCap":378042910},{"date":"2021-08-06","current":-23.202269,"twenty":-2.173818,"median":-0.944411,"eighty":-0.481618,"marketCap":427352855},{"date":"2021-08-13","current":-18.918779,"twenty":-2.194723,"median":-0.955329,"eighty":-0.481618,"marketCap":407726884},{"date":"2021-08-20","current":-19.153794,"twenty":-2.213427,"median":-0.966247,"eighty":-0.481618,"marketCap":412791814},{"date":"2021-08-27","current":-21.915231,"twenty":-2.238204,"median":-0.971483,"eighty":-0.481618,"marketCap":472304744},{"date":"2021-09-03","current":-22.032739,"twenty":-2.260964,"median":-0.978233,"eighty":-0.482893,"marketCap":474837210},{"date":"2021-09-10","current":-23.325326,"twenty":-2.270037,"median":-0.992208,"eighty":-0.482893,"marketCap":502694326},{"date":"2021-09-17","current":-21.033922,"twenty":-2.288598,"median":-0.993831,"eighty":-0.482893,"marketCap":453311256},{"date":"2021-09-24","current":-19.858842,"twenty":-2.306658,"median":-1.000057,"eighty":-0.482893,"marketCap":427986605},{"date":"2021-10-01","current":-19.095041,"twenty":-2.376607,"median":-1.011331,"eighty":-0.482893,"marketCap":411525582},{"date":"2021-10-08","current":-18.683763,"twenty":-2.40205,"median":-1.018076,"eighty":-0.482983,"marketCap":402661954},{"date":"2021-10-15","current":-16.803636,"twenty":-2.425515,"median":-1.028048,"eighty":-0.488626,"marketCap":362142512},{"date":"2021-10-22","current":-16.333604,"twenty":-2.462678,"median":-1.035775,"eighty":-0.497592,"marketCap":352012651},{"date":"2021-10-29","current":-15.09977,"twenty":-2.503041,"median":-1.055103,"eighty":-0.507425,"marketCap":325421767},{"date":"2021-11-05","current":-16.098588,"twenty":-2.562582,"median":-1.072428,"eighty":-0.531824,"marketCap":346947721},{"date":"2021-11-12","current":-15.569802,"twenty":-2.611254,"median":-1.079106,"eighty":-0.553119,"marketCap":335551628},{"date":"2021-11-19","current":-12.794512,"twenty":-2.659443,"median":-1.085262,"eighty":-0.568693,"marketCap":297566658},{"date":"2021-11-26","current":-12.413399,"twenty":-2.727565,"median":-1.09038,"eighty":-0.575917,"marketCap":288702970},{"date":"2021-12-03","current":-10.507833,"twenty":-2.792997,"median":-1.097263,"eighty":-0.587588,"marketCap":244384532},{"date":"2021-12-10","current":-10.943391,"twenty":-2.856481,"median":-1.099625,"eighty":-0.599728,"marketCap":254514461},{"date":"2021-12-17","current":-10.725612,"twenty":-2.905335,"median":-1.108181,"eighty":-0.610945,"marketCap":249449496},{"date":"2021-12-23","current":-9.800052,"twenty":-2.974256,"median":-1.108562,"eighty":-0.624983,"marketCap":227923398},{"date":"2021-12-31","current":-8.711157,"twenty":-3.128969,"median":-1.114803,"eighty":-0.633499,"marketCap":202598576},{"date":"2022-01-07","current":-8.330044,"twenty":-5.482702,"median":-1.119099,"eighty":-0.644504,"marketCap":193734888},{"date":"2022-01-14","current":-7.948931,"twenty":-7.201712,"median":-1.123862,"eighty":-0.651457,"marketCap":184871200},{"date":"2022-01-21","current":-6.860036,"twenty":-7.611374,"median":-1.135476,"eighty":-0.660331,"marketCap":159546378},{"date":"2022-01-28","current":-6.751147,"twenty":-7.589596,"median":-1.145579,"eighty":-0.668417,"marketCap":157013896},{"date":"2022-02-04","current":-6.805591,"twenty":-7.589596,"median":-1.150539,"eighty":-0.673229,"marketCap":158280137},{"date":"2022-02-11","current":-7.404483,"twenty":-7.738189,"median":-1.157174,"eighty":-0.683463,"marketCap":172208789},{"date":"2022-02-18","current":-6.860036,"twenty":-7.738189,"median":-1.172103,"eighty":-0.688731,"marketCap":159546378},{"date":"2022-02-25","current":-6.805591,"twenty":-7.738189,"median":-1.187337,"eighty":-0.703334,"marketCap":158280137},{"date":"2022-03-04","current":-7.435464,"twenty":-7.956848,"median":-1.20507,"eighty":-0.709225,"marketCap":153215173},{"date":"2022-03-11","current":-7.435464,"twenty":-7.991487,"median":-1.215898,"eighty":-0.717544,"marketCap":153215173},{"date":"2022-03-18","current":-9.586218,"twenty":-8.062425,"median":-1.232652,"eighty":-0.722939,"marketCap":197533611},{"date":"2022-03-25","current":-8.848817,"twenty":-8.340933,"median":-1.245717,"eighty":-0.724233,"marketCap":182338718},{"date":"2022-04-01","current":-7.619814,"twenty":-8.430956,"median":-1.256015,"eighty":-0.732518,"marketCap":157013896},{"date":"2022-04-08","current":-7.066763,"twenty":-8.430956,"median":-1.270862,"eighty":-0.742242,"marketCap":145617726},{"date":"2022-04-14","current":-6.820963,"twenty":-8.430956,"median":-1.279552,"eighty":-0.746236,"marketCap":140552762},{"date":"2022-04-22","current":-6.267912,"twenty":-8.430956,"median":-1.303703,"eighty":-0.748228,"marketCap":129156592},{"date":"2022-04-29","current":-6.206462,"twenty":-8.430956,"median":-1.343511,"eighty":-0.753216,"marketCap":127890351},{"date":"2022-05-06","current":-6.057138,"twenty":-8.430956,"median":-1.407132,"eighty":-0.754543,"marketCap":124813385},{"date":"2022-05-13","current":-5.714714,"twenty":-8.430956,"median":-1.428042,"eighty":-0.756108,"marketCap":124889359},{"date":"2022-05-20","current":-5.558853,"twenty":-8.430956,"median":-1.503333,"eighty":-0.758684,"marketCap":121483171},{"date":"2022-05-27","current":-5.550741,"twenty":-8.430956,"median":-1.561647,"eighty":-0.762567,"marketCap":121305897},{"date":"2022-06-03","current":-5.909975,"twenty":-8.430956,"median":-1.621295,"eighty":-0.76678,"marketCap":129156592},{"date":"2022-06-10","current":-6.547325,"twenty":-8.430956,"median":-1.636347,"eighty":-0.77591,"marketCap":143085244},{"date":"2022-06-17","current":-6.025857,"twenty":-8.430956,"median":-1.644408,"eighty":-0.78054,"marketCap":131689074},{"date":"2022-06-24","current":-6.779089,"twenty":-8.443246,"median":-1.662719,"eighty":-0.783078,"marketCap":148150208},{"date":"2022-07-01","current":-5.852034,"twenty":-8.443246,"median":-1.676651,"eighty":-0.787472,"marketCap":127890351},{"date":"2022-07-08","current":-6.25762,"twenty":-8.443246,"median":-1.684712,"eighty":-0.79295,"marketCap":136754038},{"date":"2022-07-15","current":-5.967916,"twenty":-8.443246,"median":-1.688742,"eighty":-0.79638,"marketCap":130422833},{"date":"2022-07-22","current":-5.69907,"twenty":-8.443246,"median":-1.700833,"eighty":-0.80382,"marketCap":124547474},{"date":"2022-07-29","current":-5.452821,"twenty":-8.443246,"median":-1.708894,"eighty":-0.807837,"marketCap":119165949},{"date":"2022-08-05","current":-5.794093,"twenty":-8.443246,"median":-1.724621,"eighty":-0.811954,"marketCap":126624110},{"date":"2022-08-12","current":-6.364797,"twenty":-8.443246,"median":-1.742956,"eighty":-0.815655,"marketCap":136754038},{"date":"2022-08-19","current":-5.952264,"twenty":-8.443246,"median":-1.751852,"eighty":-0.820778,"marketCap":127890351},{"date":"2022-08-26","current":-5.654651,"twenty":-8.443246,"median":-1.773381,"eighty":-0.82749,"marketCap":121495833},{"date":"2022-09-02","current":-5.379433,"twenty":-8.443246,"median":-1.784444,"eighty":-0.831091,"marketCap":115582487},{"date":"2022-09-09","current":-5.569198,"twenty":-8.443246,"median":-1.817246,"eighty":-0.836558,"marketCap":119659783},{"date":"2022-09-16","current":-5.486102,"twenty":-8.443246,"median":-1.829618,"eighty":-0.841631,"marketCap":117874383},{"date":"2022-09-23","current":-4.857873,"twenty":-8.443246,"median":-1.835652,"eighty":-0.842026,"marketCap":104376253},{"date":"2022-09-30","current":-4.910913,"twenty":-8.443246,"median":-1.853989,"eighty":-0.844965,"marketCap":105515870},{"date":"2022-10-07","current":-4.780081,"twenty":-8.443246,"median":-1.874074,"eighty":-0.847792,"marketCap":102704815},{"date":"2022-10-14","current":-4.773598,"twenty":-8.443246,"median":-1.898518,"eighty":-0.850625,"marketCap":102565529},{"date":"2022-10-21","current":-4.832531,"twenty":-8.443246,"median":-1.910415,"eighty":-0.852421,"marketCap":103831770},{"date":"2022-10-28","current":-5.775464,"twenty":-8.443246,"median":-1.922963,"eighty":-0.857816,"marketCap":124091627},{"date":"2022-11-04","current":-5.043513,"twenty":-8.443246,"median":-1.955555,"eighty":-0.863323,"marketCap":108364913},{"date":"2022-11-11","current":-4.377471,"twenty":-8.443246,"median":-1.971852,"eighty":-0.868357,"marketCap":106376914},{"date":"2022-11-18","current":-4.150807,"twenty":-8.443246,"median":-1.985886,"eighty":-0.868357,"marketCap":100868766},{"date":"2022-11-25","current":-4.272737,"twenty":-8.443246,"median":-2.000113,"eighty":-0.868357,"marketCap":103831770},{"date":"2022-12-02","current":-3.987714,"twenty":-8.443246,"median":-2.029426,"eighty":-0.868357,"marketCap":96905431},{"date":"2022-12-09","current":-3.484365,"twenty":-8.443246,"median":-2.040115,"eighty":-0.868357,"marketCap":84673542},{"date":"2022-12-16","current":-3.03729,"twenty":-8.443246,"median":-2.05551,"eighty":-0.868357,"marketCap":73809193},{"date":"2022-12-23","current":-3.000295,"twenty":-8.443246,"median":-2.068688,"eighty":-0.868808,"marketCap":72910162},{"date":"2022-12-30","current":-2.753831,"twenty":-8.443246,"median":-2.085832,"eighty":-0.871143,"marketCap":66920842},{"date":"2023-01-06","current":-3.746981,"twenty":-8.443246,"median":-2.103874,"eighty":-0.871143,"marketCap":91055397},{"date":"2023-01-13","current":-4.446251,"twenty":-8.443246,"median":-2.114405,"eighty":-0.871143,"marketCap":108048353},{"date":"2023-01-20","current":-4.202914,"twenty":-8.443246,"median":-2.12012,"eighty":-0.871143,"marketCap":102135007},{"date":"2023-01-27","current":-4.272737,"twenty":-8.443246,"median":-2.152172,"eighty":-0.871143,"marketCap":103831770},{"date":"2023-02-03","current":-4.324843,"twenty":-8.443246,"median":-2.160122,"eighty":-0.871143,"marketCap":105098011},{"date":"2023-02-10","current":-3.782935,"twenty":-8.443246,"median":-2.170132,"eighty":-0.871143,"marketCap":91929103},{"date":"2023-02-17","current":-4.180508,"twenty":-8.443246,"median":-2.171551,"eighty":-0.871143,"marketCap":101590523},{"date":"2023-02-24","current":-3.885585,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":94423598},{"date":"2023-03-03","current":-3.739687,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":90878123},{"date":"2023-03-10","current":-3.51615,"twenty":-8.443246,"median":-2.174385,"eighty":-0.871143,"marketCap":85445949},{"date":"2023-03-17","current":-3.595351,"twenty":-8.443246,"median":-2.188695,"eighty":-0.871143,"marketCap":87370635},{"date":"2023-03-24","current":-3.27081,"twenty":-8.443246,"median":-2.211554,"eighty":-0.871143,"marketCap":88181030},{"date":"2023-03-31","current":-3.404667,"twenty":-8.430956,"median":-2.238858,"eighty":-0.871736,"marketCap":91789817},{"date":"2023-04-06","current":-3.354412,"twenty":-8.430956,"median":-2.265842,"eighty":-0.871736,"marketCap":90434939},{"date":"2023-04-14","current":-3.474648,"twenty":-8.443246,"median":-2.285844,"eighty":-0.871143,"marketCap":93676516},{"date":"2023-04-21","current":-3.362866,"twenty":-8.443246,"median":-2.361747,"eighty":-0.871143,"marketCap":90662862},{"date":"2023-04-28","current":-2.975854,"twenty":-8.443246,"median":-2.393989,"eighty":-0.871143,"marketCap":80229036},{"date":"2023-05-05","current":-3.179223,"twenty":-8.443246,"median":-2.418171,"eighty":-0.871143,"marketCap":85711860},{"date":"2023-05-12","current":-3.2121,"twenty":-8.443246,"median":-2.472437,"eighty":-0.871143,"marketCap":86598228},{"date":"2023-05-19","current":-3.172389,"twenty":-8.443246,"median":-2.517777,"eighty":-0.871143,"marketCap":90270328},{"date":"2023-05-26","current":-4.297343,"twenty":-8.443246,"median":-2.651908,"eighty":-0.871143,"marketCap":122280903},{"date":"2023-06-02","current":-4.105104,"twenty":-8.443246,"median":-2.695007,"eighty":-0.871143,"marketCap":116810741},{"date":"2023-06-09","current":-4.338283,"twenty":-8.455536,"median":-2.753953,"eighty":-0.87055,"marketCap":123445844},{"date":"2023-06-16","current":-3.99964,"twenty":-8.455536,"median":-2.805078,"eighty":-0.875188,"marketCap":113809750},{"date":"2023-06-23","current":-4.05393,"twenty":-8.467826,"median":-2.839179,"eighty":-0.879396,"marketCap":115354564},{"date":"2023-06-30","current":-5.695971,"twenty":-8.480116,"median":-2.863181,"eighty":-0.884791,"marketCap":162078860},{"date":"2023-07-07","current":-5.473472,"twenty":-8.480116,"median":-2.935338,"eighty":-0.885768,"marketCap":155747655},{"date":"2023-07-14","current":-5.384473,"twenty":-8.480116,"median":-2.980152,"eighty":-0.895581,"marketCap":153215173},{"date":"2023-07-21","current":-5.072974,"twenty":-8.480116,"median":-3.014438,"eighty":-0.910372,"marketCap":144351485},{"date":"2023-07-28","current":-4.627977,"twenty":-8.480116,"median":-3.043022,"eighty":-0.917161,"marketCap":131689074},{"date":"2023-08-04","current":-4.805976,"twenty":-8.480116,"median":-3.123955,"eighty":-0.933492,"marketCap":136754038},{"date":"2023-08-11","current":-4.583477,"twenty":-8.480116,"median":-3.172611,"eighty":-0.944411,"marketCap":130422833},{"date":"2023-08-18","current":-3.510877,"twenty":-8.480116,"median":-3.196041,"eighty":-0.944411,"marketCap":110992860},{"date":"2023-08-25","current":-3.480638,"twenty":-8.480116,"median":-3.230264,"eighty":-0.944411,"marketCap":110036892},{"date":"2023-09-01","current":-3.14284,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":99357729},{"date":"2023-09-08","current":-2.958224,"twenty":-8.480116,"median":-3.276761,"eighty":-0.944411,"marketCap":93521296},{"date":"2023-09-15","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.944411,"marketCap":99370308},{"date":"2023-09-22","current":-3.143237,"twenty":-8.480116,"median":-3.287059,"eighty":-0.955329,"marketCap":99370308},{"date":"2023-09-29","current":-3.00398,"twenty":-8.480116,"median":-3.287483,"eighty":-0.999001,"marketCap":94967826},{"date":"2023-10-06","current":-2.851593,"twenty":-8.480116,"median":-3.287483,"eighty":-1.022217,"marketCap":90150252},{"date":"2023-10-13","current":-2.64589,"twenty":-8.480116,"median":-3.287483,"eighty":-1.080886,"marketCap":83647158},{"date":"2023-10-20","current":-2.625996,"twenty":-8.480116,"median":-3.287483,"eighty":-1.097263,"marketCap":83018232},{"date":"2023-10-27","current":-2.672548,"twenty":-8.481474,"median":-3.302389,"eighty":-1.107436,"marketCap":84489918},{"date":"2023-11-03","current":-2.77719,"twenty":-8.481474,"median":-3.302389,"eighty":-1.108181,"marketCap":87798069},{"date":"2023-11-10","current":-2.637932,"twenty":-8.481474,"median":-3.302389,"eighty":-1.118172,"marketCap":83395587},{"date":"2023-11-17","current":-2.866862,"twenty":-8.481474,"median":-3.302389,"eighty":-1.123293,"marketCap":85521357},{"date":"2023-11-24","current":-3.317947,"twenty":-8.481474,"median":-3.31355,"eighty":-1.135476,"marketCap":98977680},{"date":"2023-12-01","current":-3.121365,"twenty":-8.481474,"median":-3.317947,"eighty":-1.148578,"marketCap":93113449},{"date":"2023-12-08","current":-3.092802,"twenty":-8.481022,"median":-3.31733,"eighty":-1.157037,"marketCap":92261382},{"date":"2023-12-15","current":-3.065919,"twenty":-8.481022,"median":-3.31733,"eighty":-1.172421,"marketCap":91459436},{"date":"2023-12-22","current":-3.087342,"twenty":-8.481022,"median":-3.31733,"eighty":-1.199689,"marketCap":92098487},{"date":"2023-12-29","current":-4.100074,"twenty":-8.481474,"median":-3.320595,"eighty":-1.222251,"marketCap":122309296},{"date":"2024-01-05","current":-3.822423,"twenty":-8.481927,"median":-3.36404,"eighty":-1.247562,"marketCap":114026698},{"date":"2024-01-12","current":-3.79344,"twenty":-8.481927,"median":-3.386925,"eighty":-1.264543,"marketCap":113162100},{"date":"2024-01-19","current":-3.427579,"twenty":-8.48238,"median":-3.404667,"eighty":-1.279259,"marketCap":102248116},{"date":"2024-01-26","current":-3.360372,"twenty":-8.481927,"median":-3.420279,"eighty":-1.305834,"marketCap":100243251},{"date":"2024-02-02","current":-3.52671,"twenty":-8.481927,"median":-3.444381,"eighty":-1.36922,"marketCap":105205292},{"date":"2024-02-09","current":-3.948437,"twenty":-8.481927,"median":-3.461454,"eighty":-1.496,"marketCap":117785820},{"date":"2024-02-16","current":-4.242469,"twenty":-8.481927,"median":-3.475353,"eighty":-1.58074,"marketCap":126557104},{"date":"2024-02-23","current":-4.284474,"twenty":-8.481927,"median":-3.490779,"eighty":-1.630973,"marketCap":127810145},{"date":"2024-03-01","current":-4.103854,"twenty":-8.481474,"median":-3.509376,"eighty":-1.643563,"marketCap":122422070},{"date":"2024-03-08","current":-4.620511,"twenty":-8.481474,"median":-3.526647,"eighty":-1.652044,"marketCap":137834470},{"date":"2024-03-15","current":-5.040558,"twenty":-8.481474,"median":-3.544287,"eighty":-1.672882,"marketCap":150364876},{"date":"2024-03-22","current":-7.056781,"twenty":-8.481474,"median":-3.592657,"eighty":-1.672882,"marketCap":210510827},{"date":"2024-03-28","current":-7.68685,"twenty":-8.481474,"median":-3.649021,"eighty":-1.672882,"marketCap":229306437},{"date":"2024-04-05","current":-7.641157,"twenty":-8.481927,"median":-3.724744,"eighty":-1.671626,"marketCap":263138534},{"date":"2024-04-12","current":-7.369848,"twenty":-8.481927,"median":-3.751671,"eighty":-1.671626,"marketCap":221788193},{"date":"2024-04-19","current":-5.912533,"twenty":-8.481927,"median":-3.788188,"eighty":-1.671626,"marketCap":177931770},{"date":"2024-04-26","current":-6.328909,"twenty":-8.481474,"median":-3.822843,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-03","current":-6.328909,"twenty":-8.481474,"median":-3.858489,"eighty":-1.672882,"marketCap":190462177},{"date":"2024-05-10","current":-7.036747,"twenty":-8.481474,"median":-3.885585,"eighty":-1.672882,"marketCap":211763868},{"date":"2024-05-17","current":-6.819219,"twenty":-8.481474,"median":-3.91687,"eighty":-1.672882,"marketCap":202469439},{"date":"2024-05-24","current":-6.183888,"twenty":-8.481474,"median":-3.940818,"eighty":-1.672882,"marketCap":183605827},{"date":"2024-05-31","current":-5.506202,"twenty":-8.481474,"median":-3.97625,"eighty":-1.672882,"marketCap":163484640},{"date":"2024-06-07","current":-5.379136,"twenty":-8.481474,"median":-3.987714,"eighty":-1.672882,"marketCap":159711918},{"date":"2024-06-14","current":-5.209714,"twenty":-8.481927,"median":-4.011197,"eighty":-1.671626,"marketCap":154681621},{"date":"2024-06-21","current":-4.701449,"twenty":-8.48238,"median":-4.074451,"eighty":-1.676651,"marketCap":139590731},{"date":"2024-06-28","current":-4.828516,"twenty":-8.488979,"median":-4.09574,"eighty":-1.683354,"marketCap":143363454},{"date":"2024-07-05","current":-4.955582,"twenty":-8.488979,"median":-4.104479,"eighty":-1.683354,"marketCap":147136176},{"date":"2024-07-12","current":-5.421491,"twenty":-8.488979,"median":-4.121002,"eighty":-1.683354,"marketCap":160969492},{"date":"2024-07-15","current":-5.548557,"twenty":-8.488979,"median":-4.131804,"eighty":-1.683354,"marketCap":164742214},{"date":"2024-08-02","current":-5.463846,"twenty":-8.711157,"median":-4.172692,"eighty":-1.713285,"marketCap":162227066},{"date":"2024-08-09","current":-5.082648,"twenty":-8.711157,"median":-4.200465,"eighty":-1.738217,"marketCap":150908899},{"date":"2024-08-16","current":-6.21264,"twenty":-8.711157,"median":-4.227479,"eighty":-1.751216,"marketCap":160969492},{"date":"2024-08-23","current":-6.649466,"twenty":-8.711157,"median":-4.246162,"eighty":-1.776296,"marketCap":172287659},{"date":"2024-08-30","current":-6.649466,"twenty":-8.711157,"median":-4.273258,"eighty":-1.817246,"marketCap":172287659},{"date":"2024-09-06","current":-6.60093,"twenty":-8.711157,"median":-4.284474,"eighty":-1.839851,"marketCap":171030085},{"date":"2024-09-13","current":-7.280437,"twenty":-8.711157,"median":-4.324843,"eighty":-1.88874,"marketCap":188636124},{"date":"2024-09-20","current":-7.086292,"twenty":-8.711157,"median":-4.370697,"eighty":-1.913185,"marketCap":183605827},{"date":"2024-09-27","current":-6.746538,"twenty":-8.711157,"median":-4.583477,"eighty":-1.929823,"marketCap":174802808},{"date":"2024-10-04","current":-6.843611,"twenty":-8.711157,"median":-4.627977,"eighty":-1.971852,"marketCap":177317956},{"date":"2024-10-11","current":-6.746538,"twenty":-8.711157,"median":-4.729398,"eighty":-2.044171,"marketCap":174802808},{"date":"2024-10-18","current":-7.037756,"twenty":-8.711157,"median":-4.761476,"eighty":-2.084221,"marketCap":182348253},{"date":"2024-10-25","current":-6.843611,"twenty":-8.711157,"median":-4.780081,"eighty":-2.1198,"marketCap":177317956},{"date":"2024-10-31","current":-6.843611,"twenty":-8.711157,"median":-4.828516,"eighty":-2.160122,"marketCap":177317956},{"date":"2024-11-08","current":-7.280437,"twenty":-8.711157,"median":-4.85329,"eighty":-2.209268,"marketCap":188636124},{"date":"2024-11-15","current":-6.404359,"twenty":-8.711157,"median":-4.870871,"eighty":-2.256127,"marketCap":172347717},{"date":"2024-11-22","current":-5.562911,"twenty":-8.711157,"median":-4.894975,"eighty":-2.281272,"marketCap":149703492},{"date":"2024-11-29","current":-6.077129,"twenty":-8.711157,"median":-4.934835,"eighty":-2.312131,"marketCap":163541630},{"date":"2024-12-06","current":-5.609658,"twenty":-8.711157,"median":-4.985169,"eighty":-2.475809,"marketCap":150961504},{"date":"2024-12-13","current":-5.375922,"twenty":-8.711157,"median":-5.040425,"eighty":-2.60998,"marketCap":144671442},{"date":"2024-12-20","current":-4.581221,"twenty":-8.711157,"median":-5.040558,"eighty":-2.633317,"marketCap":123285228},{"date":"2024-12-27","current":-4.955198,"twenty":-8.711157,"median":-5.040558,"eighty":-2.657728,"marketCap":133349329},{"date":"2025-01-03","current":-4.488194,"twenty":-8.711157,"median":-5.040558,"eighty":-2.670479,"marketCap":120781783},{"date":"2025-01-10","current":-4.322709,"twenty":-8.711157,"median":-5.040558,"eighty":-2.691534,"marketCap":116328419},{"date":"2025-01-17","current":-3.957614,"twenty":-8.711157,"median":-5.040558,"eighty":-2.715746,"marketCap":106503341},{"date":"2025-01-24","current":-4.38909,"twenty":-8.711157,"median":-5.040558,"eighty":-2.756011,"marketCap":118114797},{"date":"2025-01-31","current":-4.045031,"twenty":-8.711157,"median":-5.040558,"eighty":-2.780373,"marketCap":108855825},{"date":"2025-02-07","current":-3.763146,"twenty":-8.711157,"median":-5.040558,"eighty":-2.822548,"marketCap":101270009},{"date":"2025-02-14","current":-3.809893,"twenty":-8.711157,"median":-5.040558,"eighty":-2.846579,"marketCap":102528022},{"date":"2025-02-21","current":-3.926293,"twenty":-8.711157,"median":-5.040558,"eighty":-2.862531,"marketCap":105660473},{"date":"2025-02-28","current":-3.482663,"twenty":-8.711157,"median":-5.040558,"eighty":-2.923981,"marketCap":93721934},{"date":"2025-03-07","current":-3.508374,"twenty":-8.711157,"median":-5.040562,"eighty":-2.950266,"marketCap":94413841},{"date":"2025-03-14","current":-3.20405,"twenty":-8.711157,"median":-5.040562,"eighty":-2.980787,"marketCap":86224179},{"date":"2025-03-21","current":-3.344759,"twenty":-8.711157,"median":-5.040562,"eighty":-3.008758,"marketCap":90010797},{"date":"2025-03-28","current":-3.538197,"twenty":-8.711157,"median":-5.040562,"eighty":-3.027033,"marketCap":90238164},{"date":"2025-04-04","current":-3.254067,"twenty":-8.711157,"median":-5.040562,"eighty":-3.056151,"marketCap":82991727},{"date":"2025-04-11","current":-2.986651,"twenty":-8.711157,"median":-5.040558,"eighty":-3.060228,"marketCap":76171551},{"date":"2025-04-17","current":-3.064141,"twenty":-8.711157,"median":-5.040558,"eighty":-3.067271,"marketCap":78147852},{"date":"2025-04-25","current":-3.710396,"twenty":-8.711157,"median":-5.040562,"eighty":-3.087342,"marketCap":94629944},{"date":"2025-05-02","current":-4.269539,"twenty":-8.711157,"median":-5.040562,"eighty":-3.101923,"marketCap":108890313},{"date":"2025-05-09","current":-4.101391,"twenty":-8.711157,"median":-5.040562,"eighty":-3.137555,"marketCap":104601869},{"date":"2025-05-16","current":-4.832598,"twenty":-8.711157,"median":-5.042039,"eighty":-3.145675,"marketCap":127309955},{"date":"2025-05-23","current":-4.265297,"twenty":-8.711157,"median":-5.042039,"eighty":-3.158264,"marketCap":112364986},{"date":"2025-05-30","current":-3.728887,"twenty":-8.711157,"median":-5.042039,"eighty":-3.172478,"marketCap":98233788},{"date":"2025-06-06","current":-4.215775,"twenty":-8.711157,"median":-5.042039,"eighty":-3.190566,"marketCap":111060369},{"date":"2025-06-13","current":-4.230484,"twenty":-8.711157,"median":-5.042039,"eighty":-3.19945,"marketCap":111447879},{"date":"2025-06-20","current":-3.938253,"twenty":-8.711157,"median":-5.043513,"eighty":-3.221964,"marketCap":103749347},{"date":"2025-06-27","current":-4.302071,"twenty":-8.711157,"median":-5.043513,"eighty":-3.242254,"marketCap":113333761},{"date":"2025-07-03","current":-4.16331,"twenty":-8.711157,"median":-5.043513,"eighty":-3.267121,"marketCap":109678250},{"date":"2025-07-11","current":-4.353555,"twenty":-8.711157,"median":-5.043513,"eighty":-3.282712,"marketCap":114690046},{"date":"2025-07-18","current":-4.263336,"twenty":-8.711157,"median":-5.043513,"eighty":-3.302389,"marketCap":112313318},{"date":"2025-07-25","current":-4.226071,"twenty":-8.711157,"median":-5.043513,"eighty":-3.320595,"marketCap":111331626},{"date":"2025-08-01","current":-4.089272,"twenty":-8.711157,"median":-5.043513,"eighty":-3.360372,"marketCap":107727783},{"date":"2025-08-08","current":-3.786744,"twenty":-8.711157,"median":-5.043513,"eighty":-3.382122,"marketCap":99757994},{"date":"2025-08-15","current":-3.508832,"twenty":-8.711157,"median":-5.043513,"eighty":-3.388701,"marketCap":100766627},{"date":"2025-08-22","current":-3.346457,"twenty":-8.711157,"median":-5.043513,"eighty":-3.398176,"marketCap":96103539},{"date":"2025-08-29","current":-3.391886,"twenty":-8.711157,"median":-5.043513,"eighty":-3.404667,"marketCap":97408170},{"date":"2025-09-05","current":-3.4688,"twenty":-8.738689,"median":-5.046907,"eighty":-3.422514,"marketCap":99617002},{"date":"2025-09-12","current":-3.702692,"twenty":-8.711157,"median":-5.043513,"eighty":-3.43178,"marketCap":106333916},{"date":"2025-09-19","current":-3.957725,"twenty":-8.711157,"median":-5.043513,"eighty":-3.444381,"marketCap":113657935},{"date":"2025-09-26","current":-3.673456,"twenty":-8.711157,"median":-5.043513,"eighty":-3.457823,"marketCap":105494301},{"date":"2025-10-03","current":-4.138091,"twenty":-8.711157,"median":-5.043513,"eighty":-3.465085,"marketCap":118837710},{"date":"2025-10-10","current":-5.307552,"twenty":-8.711157,"median":-5.0503,"eighty":-3.474716,"marketCap":152422280},{"date":"2025-10-17","current":-4.632863,"twenty":-8.711157,"median":-5.0503,"eighty":-3.477591,"marketCap":133046566},{"date":"2025-10-24","current":-4.117401,"twenty":-8.711157,"median":-5.0503,"eighty":-3.487242,"marketCap":118243521},{"date":"2025-10-31","current":-3.958174,"twenty":-8.711157,"median":-5.0503,"eighty":-3.505307,"marketCap":113670853},{"date":"2025-11-07","current":-3.66356,"twenty":-8.711157,"median":-5.0503,"eighty":-3.509376,"marketCap":105210124},{"date":"2025-11-14","current":-3.610485,"twenty":-8.711157,"median":-5.0503,"eighty":-3.5238,"marketCap":103685902},{"date":"2025-11-21","current":-3.218585,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":97136910},{"date":"2025-11-28","current":-3.327726,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":100430782},{"date":"2025-12-05","current":-3.250686,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52567,"marketCap":98105696},{"date":"2025-12-12","current":-3.872575,"twenty":-8.711157,"median":-5.0503,"eighty":-3.526548,"marketCap":116874304},{"date":"2025-12-19","current":-3.014,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52671,"marketCap":90962516},{"date":"2025-12-26","current":-2.937387,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52671,"marketCap":88650348},{"date":"2026-01-02","current":-2.52522,"twenty":-8.711157,"median":-5.0503,"eighty":-3.52671,"marketCap":76211140},{"date":"2026-01-09","current":-2.794862,"twenty":-8.711157,"median":-5.043513,"eighty":-3.526548,"marketCap":84348939},{"date":"2026-01-16","current":-2.482848,"twenty":-8.711157,"median":-5.028475,"eighty":-3.522555,"marketCap":74932343},{"date":"2026-01-23","current":-2.80171,"twenty":-8.541566,"median":-4.992697,"eighty":-3.508832,"marketCap":84555614},{"date":"2026-01-30","current":-2.56802,"twenty":-8.330044,"median":-4.955582,"eighty":-3.499024,"marketCap":77502854},{"date":"2026-02-06","current":-1.520839,"twenty":-8.111415,"median":-4.910913,"eighty":-3.484365,"marketCap":45898932},{"date":"2026-02-13","current":-1.124223,"twenty":-7.938878,"median":-4.870871,"eighty":-3.475997,"marketCap":33929042},{"date":"2026-02-20","current":-1.261184,"twenty":-7.786223,"median":-4.867891,"eighty":-3.474716,"marketCap":38062529}],"updateTime":1771849708736},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATOS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2590369349","title":"Atossa Therapeutics Granted U.S. Patent for Enteric Oral (Z)-Endoxifen Formulations and Treatment Methods","url":"https://stock-news.laohu8.com/highlight/detail?id=2590369349","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590369349?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:02","pubTimestamp":1765285339,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. announced the issuance of U.S. Patent No. 12,479,790 B2, titled \"Methods for Making and Using Endoxifen.\" The new patent covers enteric oral formulations of highly pure -endoxifen free base, methods of using these compositions to treat hormone-dependent breast disorders and other estrogen-related conditions, as well as specific solid oral dosage forms and stable formulations that provide sustained systemic exposure to -endoxifen. This patent is expected to strengthen Atossa's intellectual property portfolio supporting its endoxifen therapeutic programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on Dece","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL1fjpgk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2590346078","title":"Atossa Therapeutics Announces Issuance of U.S. Patent Covering Enteric Oral (Z)-Endoxifen Formulations and Methods of Treating Patients Using (Z)-Endoxifen","url":"https://stock-news.laohu8.com/highlight/detail?id=2590346078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590346078?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:00","pubTimestamp":1765285206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nTUA3BYZVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2588305342","title":"Atossa Therapeutics and Insilico Medicine Identify (Z)-Endoxifen as Potential Glioblastoma Treatment in AI-Driven Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2588305342","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588305342?lang=en_us&edition=fundamental","pubTime":"2025-12-02 21:02","pubTimestamp":1764680560,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc., in collaboration with Insilico Medicine, has announced the publication of a joint study evaluating -endoxifen as a potential therapeutic candidate for glioblastoma multiforme . The results of the study, which utilized Insilico's AI-powered PandaOmics platform to systematically explore new oncology indications for endoxifen, have been published in Nature Scientific Reports. The study identified GBM as a top candidate for further investigation of -endoxifen, an active metabolite of tamoxifen with known activity in endocrine-resistant breast cancer. The announcement did not specify the initiation of a clinical trial, but highlighted the publication of these preclinical findings and the potential for future therapeutic programs.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nNDL3M5N0x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2584644000","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2584644000","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584644000?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:00","pubTimestamp":1763377200,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·J & J Snack Fds                                 4Q      1.24        BMO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLT","XP","ADIL","AS","EARN","ATKR","CLCO","CRNC","ZTO","WMT","AZTA","TCOM","BV","WB","CING","CPA","CRDL","ENR","BULL","CRGO","CLSD","TGT","DY","ATOS","CPRT","BRBR","AHL","BNTC","DE","ENTA","CGON","DLB","POWL","BMA","ANRO","ARMK","VIPS","ARBE","ACM","BBWI","AREC","ATRA","NTES","CDLR","NVDA","BZ","TBBB"],"gpt_icon":1},{"id":"2583980577","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2583980577","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583980577?lang=en_us&edition=fundamental","pubTime":"2025-11-14 19:00","pubTimestamp":1763118000,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Li Auto Inc. Sp ADR                               3Q       .10. ·J & J Snack Fds                                 4Q      1.24        BMO","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BTBT","CDLR","DY","ACM","TGT","ZTO","AS","DE","BBWI","CRDL","ALLT","ADIL","CRGO","BMA","CLCO","CLSD","TCOM","BZ","ATOS","AZTA","CING","AHL","DEFT","DLB","CGON","BV","ARBE","CPA","NVDA","ARMK","CRNC","ATKR","ATRA","BNTC","BRBR","AREC","WB","NTES","ATAI","LGN","XP","BBAR","POWL","ANRO","BNZI"],"gpt_icon":1},{"id":"2582249371","title":"Atossa Therapeutics Q3 net loss widens as operating costs rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2582249371","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582249371?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:24","pubTimestamp":1762953858,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Q3 net loss widens as operating costs riseOverviewAtossa Therapeutics Q3 net loss widens to $8.7 mln, operating expenses rise to $9.3 mlnCompany advances (Z)-endoxifen program with","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nL1N3WO0H2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2582371628","title":"Atossa Therapeutics Secures Israeli Patent for (Z)-Endoxifen, Strengthening Global IP Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371628","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371628?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:15","pubTimestamp":1762953333,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics announced the issuance of a new Israeli patent  titled \"Methods for Making and Using Endoxifen.\" The patent was granted on July 2, 2025, and claims priority to multiple U.S. provisional applications filed in 2017 and 2018. This development marks continued progress in strengthening the company's global intellectual property portfolio for its lead program, -endoxifen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL8dpC0y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2582371548","title":"Atossa Therapeutics Q3 Pretax Profit USD -8.692 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371548?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:15","pubTimestamp":1762953301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXADFDB1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2582371544","title":"Atossa Therapeutics Q3 Operating Expenses USD 9.251 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582371544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582371544?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:15","pubTimestamp":1762953301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nPLXADFDB1:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2582388013","title":"Top News Today/Canada: Barrick's Interim CEO Gets to Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2582388013","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582388013?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:30","pubTimestamp":1762810200,"startTime":"0","endTime":"0","summary":"Barrick Looks to Get Handle on North American Operations, Find Growth. Barrick Mining is diving into how its core gold operations in Nevada are being run and is looking for opportunities to boost production, steps that come after parting ways with its former chief executive.Mark Hill, Barrick's interim CEO, said that the mining company is determined to grow and not just replace the resources it digs up, and to produce gold and copper safely.Since taking on the role and being named chief operating officer in late September, Hill said he has met with Barrick's teams around the world. He also spent several weeks in Nevada, which alongside an asset in the Dominican Republic, is a focus of the company's review.Barrick Looking to Reset Safety Culture  Barrick Continues Efforts to Free Workers Jailed in Mali. Burger King Strikes Joint Venture to Double Presence in China. C2AE offers a range of engineering services to clients including state and local governments, transportation agencies, and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STXS","KALV","BK4137","ACCS","CRBU","GNPX","MGNX","BK4134","BK4021","WKHS","MVIS","BK4138","BK4539","BK4082","LPTH","BK4139","BK4079","BK4547","BK4551","BK4179","BK4023","PRLD","BK4168","CLDX","DOX","SSTI","SLSN","WHLM","CENN","IE00BFMHRM44.USD","BK4505","BK4109","SYPR","LU0205193047.USD","EVI","LU0205194284.USD","IPSC","SND","PVLA","GIFI","NRDE","ATRA","QUIK","ATOS","AMTX","FTHM","NMM","BK4099","MGTX"],"gpt_icon":1},{"id":"2581884105","title":"Atossa Therapeutics Inc  expected to post a loss of 7 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2581884105","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581884105?lang=en_us&edition=fundamental","pubTime":"2025-11-07 23:21","pubTimestamp":1762528866,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc  expected to post a loss of7cents a share - Earnings Preview Atossa Therapeutics Inc ATOS.OQ ATOS.O is expected to  show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nL8N3WJ24Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2577827161","title":"Atossa Therapeutics Advances RECAST Trial Testing (Z)-Endoxifen for DCIS","url":"https://stock-news.laohu8.com/highlight/detail?id=2577827161","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577827161?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:00","pubTimestamp":1761048057,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. has announced progress in the RECAST platform trial, which is focused on ductal carcinoma in situ , a non-invasive breast condition. The company highlighted enrollment momentum, its biomarker strategy, and plans for near-term data readouts that aim to de-risk development of -Endoxifen and other endocrine therapies for DCIS. Laura J. Esserman, MD, MBA, Principal Investigator of RECAST, will discuss the active-surveillance strategy and novel endocrine agents at the Early Detection Research Conference in Portland, OR. Results from the trial are expected in the future, as interim readout opportunities are anticipated to guide further development and payer-relevant modeling.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal ad","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251021:nNDL4wWWy4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2576720999","title":"Health Rounds: Scientists find way to make breast cancer drug work better for younger women","url":"https://stock-news.laohu8.com/highlight/detail?id=2576720999","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576720999?lang=en_us&edition=fundamental","pubTime":"2025-10-17 03:38","pubTimestamp":1760643501,"startTime":"0","endTime":"0","summary":"Health Rounds: Scientists find way to make breast cancer drug work better for younger womenHealth Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us?Forward this newsletter to them. They can also subscribe hereBy Nancy LapidOct 16  - Hello Health Rounds readers!","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251016:nL2N3VV0UP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2575290411","title":"Atossa Therapeutics appoints Mark Daniel as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2575290411","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575290411?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:11","pubTimestamp":1760443901,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics (ATOS) appointed Mark Daniel as CFO. Daniel is a senior finance leader with more than 25 years of experience , having overseen ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-appoints-mark-daniel-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atossa-therapeutics-appoints-mark-daniel-as-cfo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LENZ","BK4007","ATOS","BK4539"],"gpt_icon":0},{"id":"2575109297","title":"Atossa Appoints Mark Daniel, Cpa, as Chief Financial Officer to Lead Finance, Systems, and Capital Strategy for Commercial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2575109297","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575109297?lang=en_us&edition=fundamental","pubTime":"2025-10-14 20:01","pubTimestamp":1760443301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nTUAB914FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2575884297","title":"BRIEF-Atossa Therapeutics - Appoints Mark Daniel As CFO - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575884297","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575884297?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:52","pubTimestamp":1760442760,"startTime":"0","endTime":"0","summary":"BRIEF-Atossa Therapeutics - Appoints Mark Daniel As CFO - SEC FilingOct 14  - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS - APPOINTS MARK DANIEL AS CFO - SEC FILINGATOSSA THERAPEUTICS - HEATHER REES STEPS DOWN AS CFO, ASSISTS TRANSITION UNTIL NOV 15 - SEC FILINGSource text: [ID:n0001193125-25-238065]Further company coverage: ATOS.O","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU308:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2575292072","title":"Atossa Therapeutics - Heather Rees Steps Down as CFO, Assists Transition Until Nov 15 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292072","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575292072?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:51","pubTimestamp":1760442677,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nFWN3VU308:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATOS"],"gpt_icon":0},{"id":"2575292021","title":"Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer to Lead Commercial Readiness","url":"https://stock-news.laohu8.com/highlight/detail?id=2575292021","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575292021?lang=en_us&edition=fundamental","pubTime":"2025-10-14 19:50","pubTimestamp":1760442656,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. has announced the appointment of Mark Daniel as Chief Financial Officer. Daniel brings over 25 years of experience in life sciences finance and will lead Atossa's finance, systems, and capital strategy as the company prepares for commercial operations with its breast cancer treatment candidate, -endoxifen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL3QtJ5q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2575405973","title":"Atossa Therapeutics Granted Israeli Patent for High-Purity Z-Endoxifen Formulations","url":"https://stock-news.laohu8.com/highlight/detail?id=2575405973","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575405973?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:00","pubTimestamp":1760356851,"startTime":"0","endTime":"0","summary":"Atossa Therapeutics Inc. announced the issuance of a new patent in Israel for its Z-endoxifen program. The granted patent, No. 304863, covers high-purity Z-endoxifen enteric formulations, performance characteristics, and manufacturing methods. The protection includes oral, delayed-release dosage forms containing at least 90% by weight Z-endoxifen, specific impurity limits, defined release characteristics, various dose strengths, and pharmacokinetic performance targets. The company also received confirmation of the patent's renewal status from the Israel Patent Office.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Atossa Therapeutics Inc. published the original content used to generate this news brief via PR Newswire  on October 13, 20","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251013:nNDLLRTqV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATOS","BK4139"],"gpt_icon":0},{"id":"2573729156","title":"BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling Activities","url":"https://stock-news.laohu8.com/highlight/detail?id=2573729156","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573729156?lang=en_us&edition=fundamental","pubTime":"2025-10-06 20:24","pubTimestamp":1759753450,"startTime":"0","endTime":"0","summary":"BRIEF-Atossa Therapeutics Streamlines Evangeline Breast Cancer Clinical Trial To Prioritize For 2026 NDA-Enabling ActivitiesOct 6 (Reuters) - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS STREAML","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251006:nTUA73NFWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATOS"],"gpt_icon":1}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":53,"code":"91000000","status":"200"}]}}